Astria Therapeutics Inc

-0.61 (-10.66%)
Earnings Announcements

Astria Therapeutics Posts Q3 Loss Per Share $0.61

Published: 11/10/2021 15:15 GMT
Astria Therapeutics Inc (ATXS) - Astria Therapeutics Reports Third Quarter 2021 Financial Results and Provides a Corporate Update.
Q3 Loss per Share $0.61.
As of September 30, 2021, Astria Had Cash and Cash Equivalents of $131.8 Million.
Expects It Has Sufficient Cash to Fund Its Current Operating Plan Through 2023.
Q3 Earnings per Share View $-0.77 -- Refinitiv Ibes Data (analyst estimates).
Revenue is expected to be $0 Million
Adjusted EPS is expected to be -$0.61

Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be -$0.59

More details on our Analysts Page.